Schaper Benz & Wise Investment Counsel Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Schaper Benz & Wise Investment Counsel Inc

  • $1.21 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
BUY
$0.5 - $1.06 $92 - $196
185 Added 1.29%
14,493 $12,000
Q4 2019

Jan 30, 2020
BUY
$0.63 - $2.27 $9,014 - $32,479
14,308 New
14,308 $32,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Schaper Benz & Wise Investment Counsel Inc Portfolio

Follow Schaper Benz & Wise Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email